RobertoCArduinoMD

Clinical Trials

• Long-Term Data Collection From Participants in Adult AIDS Clinical Trials Start of enrollment: 2000 Jan 01

  Completed

• "The Once A Day Protease Inhibitor Regimens" Start of enrollment: 2004 May 01

  Completed

  Phase 4

• Collection of Blood Samples From SMART Study Participants for Future Genetic Studies

  Completed

• Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals Start of enrollment: 2010 Dec 01

  Completed

  Phase 1

• FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir Start of enrollment: 2013 Apr 25

  Completed

  Phase 4

• Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study) Start of enrollment: 2014 Jan 01

  Completed

  Phase 2

• Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery Start of enrollment: 2014 Jul 02

  Completed

  Phase 2

• Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection Start of enrollment: 2014 May 30

  Completed

  Phase 1

• PRO 140 for Human Immunodeficiency Virus Infection Start of enrollment: 2014 Sep 01

  Withdrawn

  Phase 2

• Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy (ART) Start of enrollment: 2015 Dec 21

  Completed

  Phase 1, Phase 2

• PREPARE (A5361s) Substudy of REPRIEVE (A5332) Start of enrollment: 2017 Feb 28

  Completed

• A Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV Start of enrollment: 2023 May 30

  Active, not recruiting

  Phase 2

  Roles: Contact

• Join now to see all